---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-013212"
form_type: "8-K"
ticker: "TERN"
cik: "0001831363"
company_name: "Terns Pharmaceuticals, Inc."
filed_at: "2022-07-27T23:59:59+00:00"
generated_at: "2026-06-24T08:18:00.196098+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Terns appoints Dr. Radhika Tripuraneni to board of directors

## Summary
- Dr. Tripuraneni appointed as Class II director and Audit Committee member effective July 26, 2022.
- She is Chief Development Officer of Prothena Corporation plc with over 15 years of drug development experience.
- No material transaction or arrangement exists with Dr. Tripuraneni or any related party.

## SEC filing metadata
- accession: 0000950170-22-013212
- form_type: 8-K
- ticker: TERN
- cik: 0001831363
- company_name: Terns Pharmaceuticals, Inc.
- filed_at: 2022-07-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831363/000095017022013212/0000950170-22-013212-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831363/000095017022013212/tern-20220726.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-013212
- JSON: https://secwatch.observer/filing/0000950170-22-013212.json
- Plain text: https://secwatch.observer/filing/0000950170-22-013212.txt

## Key facts
- Executive change
  Radhika Tripuraneni was appointed as Director at Terns Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Director
  source text: On July 26, 2022, the Board of Directors (the “Board”) of Terns Pharmaceuticals, Inc. (the “Company”) appointed Radhika Tripuraneni, M.D., M.P.H. to serve as a Class II director until her successor is duly elected and qualified or until her earlier death, resignation or removal.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831363/000095017022013212/0000950170-22-013212-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.